Beta-blockers and mortality reduction in heart failure: a systematic review of randomized controlled trials

HIGHLIGHTS

• What: The aim of this Page 5 of 15 systematic review is to bring together results from different RCTs to see whether beta blockers reduce mortality and hospitalizations in HF patient . By offering a comprehensive analysis, the review seeked to affirm the therapeutic role of beta-blockers in HFrEF, explore their potential in HFpEF, and address any gaps in the current literature. This Systematic Review was conducted from September 2023 till august 2024. Since this Page 6 of 15 review used data from previously published studies, all assumed to have been conducted following ethical standards, this review . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.